How This CRISPR Biotech Could Make Investors Rich Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a biotech company that represents a solid trend in the industry. Source: BioSpace You Might Also Like DNAnexus Announces Two Key Executive Appointments March 15, 2017 Taxus Cardium Release: Excellagen Receives Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration June 12, 2017 Mylan Teams Up with Revance Therapeutics to Develop Botox Biosimilar February 28, 2018
Taxus Cardium Release: Excellagen Receives Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration June 12, 2017
